Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2024 年第 2 季持倉
持倉截至 2024/6/30，2024/8/14 申報。只含多頭部位，變化是跟 2024 年第 1 季比股數。
- 持股檔數
- 86
- 較 2024 年第 1 季 +9
- 總值
- $6.35 億
- 較 2024 年第 1 季 +$1,981 萬 (+3.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| XENEXenon Pharmaceuticals Inc. | COM | 994,227 | $3,876 萬 | 6.1% | +156,840+18.7% | 加碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 836,283 | $3,291 萬 | 5.2% | +244,190+41.2% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 110,000 | $3,082 萬 | 4.9% | −5,000−4.3% | 減碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 460,000 | $2,539 萬 | 4.0% | +160,000+53.3% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,450,000 | $2,356 萬 | 3.7% | +50,000+3.6% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 515,000 | $2,307 萬 | 3.6% | +45,000+9.6% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 500,000 | $2,045 萬 | 3.2% | +200,000+66.7% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 912,000 | $1,903 萬 | 3.0% | +101,747+12.6% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 475,400 | $1,759 萬 | 2.8% | −34,600−6.8% | 減碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $1,726 萬 | 2.7% | – | – | – |
| Alnylam Pharmaceuticals, Inc.02043QAB3 | NOTE 1.000% 9/1 | – | $1,620 萬 | 2.6% | – | – | – |
| ONCBeOne Medicines Ltd. | ADR | 110,000 | $1,569 萬 | 2.5% | +27,857+33.9% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 650,000 | $1,567 萬 | 2.5% | +575,000+766.7% | 加碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 200,000 | $1,517 萬 | 2.4% | +50,000+33.3% | 加碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 4,300,000 | $1,496 萬 | 2.4% | +925,000+27.4% | 加碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 375,000 | $1,357 萬 | 2.1% | −95,000−20.2% | 減碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 650,000 | $1,338 萬 | 2.1% | −80,492−11.0% | 減碼 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 2,856,252 | $1,274 萬 | 2.0% | +213,733+8.1% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 513,420 | $1,207 萬 | 1.9% | +103,420+25.2% | 加碼 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 1,670,661 | $1,188 萬 | 1.9% | +1,670,661 | 新進 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,135,702 | $1,026 萬 | 1.6% | +305,156+36.7% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 223,407 | $1,015 萬 | 1.6% | +58,818+35.7% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 700,000 | $1,012 萬 | 1.6% | −117,833−14.4% | 減碼 | 歷史 |
| NARIInari Medical, Inc. | Stock | 200,000 | $963.0 萬 | 1.5% | +25,000+14.3% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 346,088 | $913.7 萬 | 1.4% | +61,088+21.4% | 加碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 975,606 | $887.8 萬 | 1.4% | +130,000+15.4% | 加碼 | 歷史 |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $863.6 萬 | 1.4% | – | – | – |
| MORFMorphic Holding, Inc. | COM | 250,573 | $853.7 萬 | 1.3% | +25,573+11.4% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 125,000 | $837.5 萬 | 1.3% | +125,000 | 新進 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 423,155 | $812.9 萬 | 1.3% | +136,955+47.9% | 加碼 | 歷史 |
| Omeros Corp682143AG7 | NOTE 5.250% 2/1 | – | $808.3 萬 | 1.3% | – | – | – |
| RZLTRezolute, Inc. | COM NEW | 1,850,000 | $795.5 萬 | 1.3% | +250,000+15.6% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 125,000 | $739.6 萬 | 1.2% | +125,000 | 新進 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 80,000 | $644.0 萬 | 1.0% | −59,758−42.8% | 減碼 | 歷史 |
| GERNGeron Corp | COM | 1,500,000 | $636.0 萬 | 1.0% | −1,000,000−40.0% | 減碼 | 歷史 |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $629.6 萬 | 1.0% | – | 新進 | – |
| SVRASavara Inc | COM | 1,546,850 | $623.4 萬 | 1.0% | +396,850+34.5% | 加碼 | 歷史 |
| ERASErasca, Inc. | COM | 2,499,431 | $589.9 萬 | 0.9% | +2,499,431 | 新進 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 550,000 | $548.4 萬 | 0.9% | +550,000 | 新進 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 155,000 | $529.9 萬 | 0.8% | −5,000−3.1% | 減碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 263,817 | $460.1 萬 | 0.7% | +5,229+2.0% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 60,000 | $453.1 萬 | 0.7% | −20,000−25.0% | 減碼 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 1,468,825 | $396.6 萬 | 0.6% | +200,000+15.8% | 加碼 | 歷史 |
| HLVXHilleVax, Inc. | COM | 265,859 | $384.4 萬 | 0.6% | +265,859 | 新進 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 327,959 | $383.7 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 351,587 | $371.6 萬 | 0.6% | −148,413−29.7% | 減碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 100,000 | $352.9 萬 | 0.6% | +100,000 | 新進 | 歷史 |
| FRNMFreenome, Inc. | CL A ORD SHS | 350,000 | $352.1 萬 | 0.6% | +350,000 | 新進 | 歷史 |
| IMTXImmatics N.V. | SHS | 300,000 | $348.6 萬 | 0.5% | −50,000−14.3% | 減碼 | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 37,550 | $348.1 萬 | 0.5% | +37,550 | 新進 | – |
| CNTXContext Therapeutics Inc. | COM | 1,619,140 | $324.6 萬 | 0.5% | +1,290,323+392.4% | 加碼 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 650,000 | $302.9 萬 | 0.5% | +650,000 | 新進 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 500,512 | $302.3 萬 | 0.5% | −527,356−51.3% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 275,000 | $297.6 萬 | 0.5% | +275,000 | 新進 | 歷史 |
| NXTCNextCure, Inc. | COM | 1,687,955 | $268.4 萬 | 0.4% | +328,918+24.2% | 加碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 69,999 | $263.7 萬 | 0.4% | −30,001−30.0% | 減碼 | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 250,000 | $255.5 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 100,000 | $253.3 萬 | 0.4% | +50,000+100.0% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 150,000 | $195.2 萬 | 0.3% | +150,000 | 新進 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 202,599 | $191.7 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 375,000 | $187.1 萬 | 0.3% | +88,415+30.9% | 加碼 | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 200,000 | $178.0 萬 | 0.3% | +200,000 | 新進 | 歷史 |
| ZYMEZymeworks Inc. | COM | 191,127 | $162.6 萬 | 0.3% | +191,127 | 新進 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 767,000 | $154.2 萬 | 0.2% | −233,000−23.3% | 減碼 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 133,500 | $153.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ADCTADC Therapeutics SA | SHS | 474,744 | $150.0 萬 | 0.2% | +474,744 | 新進 | 歷史 |
| KYTXKyverna Therapeutics, Inc. | COM | 200,000 | $150.0 萬 | 0.2% | +200,000 | 新進 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 50,000 | $129.9 萬 | 0.2% | −70,000−58.3% | 減碼 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 150,274 | $128.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NKTXNkarta, Inc. | COM | 200,000 | $118.2 萬 | 0.2% | +200,000 | 新進 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 1,761,778 | $105.7 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 58,331 | $96.1 萬 | 0.2% | 00.0% | 不變依 1 比 12 拆股換算 | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 250,000 | $81.5 萬 | 0.1% | +250,000 | 新進 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 223,335 | $78.2 萬 | 0.1% | −226,674−50.4% | 減碼 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 45,000 | $56.1 萬 | 0.1% | +35,000+350.0% | 加碼 | 歷史 |
| QTTBQ32 Bio Inc. | COM | 27,777 | $49.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $48.5 萬 | 0.1% | 00.0% | 不變 | – |
| MTVAMetaVia Inc. | COM | 89,222 | $43.2 萬 | 0.1% | +89,222 | 新進 | 歷史 |
| PMNProMIS Neurosciences Inc. | COM | 265,958 | $39.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 200,000 | $33.2 萬 | 0.1% | +200,000 | 新進 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 72,484 | $27.8 萬 | <0.1% | +72,484 | 新進 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 75,000 | $22.9 萬 | <0.1% | +75,000 | 新進 | 歷史 |
| PASGPassage BIO, Inc. | COM | 264,266 | $21.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| GNLXGENELUX Corp | COM | 100,000 | $19.5 萬 | <0.1% | +100,000 | 新進 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $4,523 | <0.1% | 00.0% | 不變 | – |
| IOVAIovance Biotherapeutics, Inc. | COM | 100 | $802 | <0.1% | +100 | 新進 | 歷史 |
選擇權（12 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | $1.90 億 | – |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $1,869 萬 |
| CERECerevel Therapeutics Holdings, Inc. | COM | – | $1,022 萬 |
| SANASana Biotechnology, Inc. | COM | $284.5 萬 | – |
| TWSTTwist Bioscience Corp | COM | – | $221.8 萬 |
| RAPTRAPT Therapeutics, Inc. | COM | $166.2 萬 | – |
| FULCFulcrum Therapeutics, Inc. | COM | – | $155.0 萬 |
| IMVTImmunovant, Inc. | COM | – | $143.4 萬 |
| IOVAIovance Biotherapeutics, Inc. | COM | $120.3 萬 | – |
| PCVXVaxcyte, Inc. | COM | – | $113.3 萬 |
| ALXOAlx Oncology Holdings Inc | COM | – | $60.3 萬 |
| INSMINSMED Inc | COM PAR $.01 | $58.3 萬 | – |
2024 年第 1 季之後清倉（16 檔）
2024 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 1 季股數 | 2024 年第 1 季市值 | 2024 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 165,000 | $969.9 萬 | 1.6% | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM | 5,100,000 | $606.9 萬 | 1.0% | 歷史 |
| ABSIAbsci Corp | COM | 1,025,000 | $582.2 萬 | 0.9% | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 80,000 | $560.9 萬 | 0.9% | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 550,339 | $519.5 萬 | 0.8% | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 26,746 | $475.9 萬 | 0.8% | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 50,000 | $410.0 萬 | 0.7% | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 75,000 | $376.7 萬 | 0.6% | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 50,000 | $346.0 萬 | 0.6% | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 450,000 | $295.2 萬 | 0.5% | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 100,000 | $289.3 萬 | 0.5% | 歷史 |
| RGNXREGENXBIO Inc. | COM | 110,000 | $231.8 萬 | 0.4% | 歷史 |
| BSXBoston Scientific Corp | Stock | 25,000 | $171.2 萬 | 0.3% | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 50,000 | $114.5 萬 | 0.2% | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 125,000 | $96.4 萬 | 0.2% | 歷史 |
| Cassava Sciences Inc14817C115 | *W EXP 11/15/202 | 24,200 | $9.75 萬 | <0.1% | – |